Jinhai Medical Technology Limited (HKG:2225)
Hong Kong · Delayed Price · Currency is HKD 5.43
+0.59 (12.20%)
Aug 24, 2026, 4:08 PM HKT
Jinhai Medical Technology Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25,621 | 6,613 | 9,823 | 3,076 | 2,681 | 3,444 | |
Market Cap Growth | 389.21% | -32.68% | 219.33% | 14.72% | -22.14% | 102.90% |
Enterprise Value | 25,480 | 6,663 | 9,787 | 2,986 | 2,560 | 3,307 |
Last Close Price | 4.83 | 1.25 | 1.90 | 0.59 | 0.55 | 0.70 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 985.27 | - |
PS Ratio | 91.49 | 23.61 | 34.35 | 11.39 | 20.70 | 27.20 |
PB Ratio | 81.48 | 21.03 | 52.65 | 13.86 | 18.75 | 24.79 |
P/TBV Ratio | 83.40 | 21.53 | 55.17 | 13.87 | 18.92 | 24.53 |
P/FCF Ratio | - | - | - | - | 150.54 | 217.95 |
P/OCF Ratio | - | - | - | - | 108.73 | 178.33 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 90.99 | 23.79 | 34.23 | 11.06 | 19.76 | 26.11 |
EV/EBITDA Ratio | - | - | - | - | 123.30 | 245.78 |
EV/FCF Ratio | - | - | - | - | 143.75 | 209.28 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.29 | 0.29 | 0.44 | 0.27 | 0.18 | 0.08 |
Debt / EBITDA Ratio | - | - | - | - | 1.01 | 0.48 |
Debt / FCF Ratio | - | - | - | - | 1.45 | 0.68 |
Net Debt / Equity Ratio | -0.46 | -0.46 | -0.08 | -0.53 | -0.88 | -1.00 |
Net Debt / EBITDA Ratio | 1.67 | 1.67 | 0.17 | 15.11 | -6.05 | -10.34 |
Net Debt / FCF Ratio | 4.23 | 4.23 | 0.64 | 6.36 | -7.05 | -8.80 |
Asset Turnover | 0.63 | 0.63 | 0.83 | 0.89 | 0.60 | 0.60 |
Inventory Turnover | 13.54 | 13.54 | 15.93 | 22.00 | 13.28 | - |
Quick Ratio | 1.60 | 1.60 | 1.02 | 1.77 | 2.11 | 2.99 |
Current Ratio | 1.84 | 1.84 | 1.29 | 2.01 | 2.38 | 3.24 |
Return on Equity (ROE) | -41.05% | -41.05% | -51.96% | -13.25% | 0.48% | -2.01% |
Return on Assets (ROA) | -15.24% | -15.24% | -20.74% | -5.60% | - | -2.45% |
Return on Invested Capital (ROIC) | -64.33% | -62.06% | -84.55% | -44.90% | - | -57.15% |
Return on Capital Employed (ROCE) | -33.50% | -33.50% | -56.60% | -11.20% | - | -5.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.40% | -1.56% | -1.04% | -0.60% | 0.10% | -0.04% |
FCF Yield | -0.13% | -0.52% | -0.25% | -0.60% | 0.66% | 0.46% |
Buyback Yield / Dilution | -0.88% | -0.88% | -4.00% | -1.04% | - | - |
Total Shareholder Return | -0.88% | -0.88% | -4.00% | -1.04% | - | - |